BillionToOne Faces Short Report Alleging Kickbacks, Flawed Diagnostic Tests
Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
Follow the latest Natera, Inc. (NTRA) news and market headlines alongside the live NTRA price. Stay informed on what's moving NTRA.
Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
Druckenmiller’s Duquesne bought a $30M SpaceX stake, halved Tesla call exposure, boosted Amazon and exited Alphabet in Q3.
Natera Inc. (NASDAQ:NTRA) short sellers added to their positions as of the latest settlement date.Short interest rose 3.77% to 6.07 million shares as of the Oct. 30 settlement date, from 5.85 million at the Oct. 15
CNBC traders picked Micron, Digital Realty, Natera and Moody’s; Natera raised FY2026 sales guidance after strong results, while Moody’s missed estimates.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to NTRA, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.